Volume 28, Number 6—June 2022
Research
Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015–2019
Table 2
Characteristics | Univariable analysis |
Multivariable analysis |
|||
---|---|---|---|---|---|
Odds ratio (95% CI) | p value | Adjusted odds ratio (95% CI) | p value | ||
All-cause mortality | |||||
Sex | |||||
M | Referent | Referent | |||
F | 1.15 (0.91–1.45) | 0.2484 | 1.26 (0.93–1.70) | NS | |
Age group, y | |||||
<65 | Referent | Referent | |||
>65 | 2.66 (2.00–3.53) | <0.0001 | 3.63 (2.45–5.39) | <0.0001 | |
Severe CDI† | 2.53 (1.90–3.36) | <0.0001 | 2.66 (1.90–3.73) | <0.0001 | |
CDI case type | |||||
Community-associated | Referent | Referent | |||
Healthcare-associated | 1.65 (1.21–2.24) | 0.0014 | 1.83 (1.23–2.72) | 0.0028 | |
RT027 vs. non-RT027 | 1.48 (1.04–2.10) | 0.0289 | 1.10 (0.74–1.63) | NS | |
RT106 vs. non-RT106 |
1.09 (0.73–1.63) |
0.6804 |
NA |
||
CDI-attributable mortality | |||||
Sex | |||||
M | Referent | Referent | |||
F | 1.22 (0.79–1.87) | 0.3776 | 1.33 (0.81–1.19) | NS | |
Age group, y | |||||
<65 | Referent | Referent | |||
>65 | 3.28 (1.84–5.85) | <0.0001 | 3.44 (1.73–6.82) | 0.0004 | |
Severe CDI† | 2.40 (1.45–4.0) | 0.0006 | 2.25 (1.28–3.94) | 0.0050 | |
CDI case type | |||||
Community-associated | Referent | Referent | |||
Healthcare-associated | 1.29 (0.76–2.22) | 0.3476 | 1.25 (0.67–2.35) | NS | |
RT027 vs. non-RT027 | 3.17 (1.89–5.29) | <0.0001 | 2.85 (1.64–5.00) | 0.0002 | |
RT106 vs. non-RT106 | 0.95 (0.45–2.00) | 0.8830 | NA |
*Bold text indicates statistical significance. CDI, Clostridioides difficile infection; NA, not applicable; NS, not significant; RT, ribotype. †Severe CDI defined as albumin level <30 g/L, leukocyte count >15 × 109 cells/L, or both.
1These authors contributed equally to this article.
Page created: April 01, 2022
Page updated: May 22, 2022
Page reviewed: May 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.